Peapod Bio Inc., announced a strategic collaboration with Enamine, a global supplier of high-quality small molecule libraries. This partnership enables Peapod Bio to offer its clients fully integrated ...

Enamine’s agile IDD Platform of Computer-aided Drug Design (CADD), together with AI/ML approaches, innovative medicinal chemistry, and preclinical biology, including its capabilities in guiding ...

Partnership unites advanced screening solutions with world-class small molecule libraries. Peapod Bio Inc., a leader in innovative assay development and high-throughput screening (HTS) solutions, ...

Partnership unites advanced screening solutions with world-class small molecule libraries. CHICAGO--(BUSINESS WIRE)--#AssayDevelopment--Peapod Bio Inc., a leader in innovative assay development and ...

Enamine, a leading chemistry and R&D services company, today announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of a ...

The MarketWatch News Department was not involved in the creation of this content. -- Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) ...

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated ...

The Institute of Cancer Research and Enamine Ltd. have announced a new research collaboration aimed at broadening the tools available for researchers working in fragment-based drug discovery (FBDD).

As a young man, I was privileged to be an eyewitness to the rise of the Christian spiritual formation movement. It began, in its modern form, in 1978, when Richard Foster wrote what has become the ...